{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:15:29Z","timestamp":1767892529875,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Affective Disorders"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.jad.2007.02.006","type":"journal-article","created":{"date-parts":[[2007,3,27]],"date-time":"2007-03-27T11:16:30Z","timestamp":1174994190000},"page":"S45-S53","source":"Crossref","is-referenced-by-count":19,"special_numbering":"S1","title":["Rates of remission\/euthymia with quetiapine monotherapy compared with placebo in patients with acute mania"],"prefix":"10.1016","volume":"100","author":[{"given":"Terence A.","family":"Ketter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Jones","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Paulsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jad.2007.02.006_bib1","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jad.2007.02.004","article-title":"Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder","volume":"100","author":"Adler","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2007.02.006_bib2","first-page":"1","article-title":"Practice guideline for the treatment of patients with bipolar disorder (revision)","volume":"159","author":"American Psychiatric Association","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib3","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jama.271.12.918","article-title":"Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group","volume":"271","author":"Bowden","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.jad.2007.02.006_bib4","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4088\/JCP.v66n0116","article-title":"A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder","volume":"66","author":"Bowden","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4088\/JCP.v60n0203","article-title":"A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group","volume":"60","author":"Calabrese","year":"1999","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib6","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1176\/appi.ajp.162.7.1351","article-title":"A randomized, double-blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression","volume":"162","author":"Calabrese","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib7","first-page":"38","article-title":"Remission with risperidone in combination with mood stabilizers in acute bipolar mania (abstract P35)","volume":"5","author":"Canuso","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2007.02.006_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-5618.2003.02237.x","article-title":"Rates of response, euthymia and remission in two placebo-controlled olanzapine trials for bipolar mania","volume":"5","author":"Chengappa","year":"2003","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2007.02.006_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1399-5618.2004.00171.x","article-title":"Recovery and functional outcomes following olanzapine treatment for bipolar I mania","volume":"7","author":"Chengappa","year":"2005","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.jad.2007.02.006_bib10","first-page":"321","article-title":"Quality of Life Enjoyment and Satisfaction Questionnaire: a new measure","volume":"29","author":"Endicott","year":"1993","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.jad.2007.02.006_bib11","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.4088\/JCP.v66n0809","article-title":"Symptomatic remission in patients with bipolar mania: results from a double-blind, placebo-controlled trial of risperidone monotherapy","volume":"66","author":"Gopal","year":"2005","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib12","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1176\/appi.ajp.161.6.1057","article-title":"Rapid antimanic effect of risperidone monotherapy: a 3-week multicenter, double-blind, placebo-controlled trial","volume":"161","author":"Hirschfeld","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib13","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1176\/appi.ajp.160.9.1651","article-title":"A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1176\/appi.ajp.160.4.741","article-title":"Ziprasidone in the treatment of acute bipolar mania: a three-week, placebo-controlled, double-blind, randomized trial","volume":"160","author":"Keck","year":"2003","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib15","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1176\/appi.ajp.159.10.1711","article-title":"The prognostic significance of \u201cswitching\u201d in patients with bipolar disorder: a 10-year prospective follow-up study","volume":"159","author":"Maj","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib16","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.euroneuro.2005.02.006","article-title":"Quetiapine or haloperidol as monotherapy for bipolar mania\u2014a 12-week, double-blind, randomised, parallel-group, placebo-controlled trial","volume":"15","author":"McIntyre","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2007.02.006_bib17","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1192\/bjp.134.4.382","article-title":"A new depression scale designed to be sensitive to change","volume":"134","author":"Montgomery","year":"1979","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.euroneuro.2004.06.003","article-title":"Acute and continuation risperidone monotherapy in bipolar mania: a 3-week placebo-controlled trial followed by a 9-week double-blind trial of risperidone and haloperidol","volume":"15","author":"Smulevich","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.jad.2007.02.006_bib19","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0022-3956(00)00015-7","article-title":"Eight-month functional outcome from mania following a first psychiatric hospitalization","volume":"34","author":"Strakowski","year":"2000","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.jad.2007.02.006_bib20","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1176\/ajp.156.5.702","article-title":"Olanzapine versus placebo in the treatment of acute mania. Olanzapine HGEH Study Group","volume":"156","author":"Tohen","year":"1999","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib21","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1001\/archpsyc.57.9.841","article-title":"Efficacy of olanzapine in acute bipolar mania: a double-blind, placebo-controlled study. The Olanzapine HGGW Study Group","volume":"57","author":"Tohen","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib22","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1176\/appi.ajp.159.6.1011","article-title":"Olanzapine versus divalproex in the treatment of acute mania","volume":"159","author":"Tohen","year":"2002","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib23","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/archpsyc.60.12.1218","article-title":"A 12-week, double-blind comparison of olanzapine vs haloperidol in the treatment of acute mania","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib24","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1001\/archpsyc.60.11.1079","article-title":"Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression","volume":"60","author":"Tohen","year":"2003","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib25","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.4088\/JCP.v65n1019","article-title":"Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data","volume":"65","author":"Vieta","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib29","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1192\/bjp.187.3.235","article-title":"Effectiveness of aripiprazole v. haloperidol in acute bipolar mania: double-blind, randomised, comparative 12-week trial","volume":"187","author":"Vieta","year":"2005","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib26","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.jad.2007.02.009","article-title":"Quetiapine in the treatment of acute mania: Target dose for efficacious treatment","volume":"100","author":"Vieta","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.jad.2007.02.006_bib27","doi-asserted-by":"crossref","first-page":"478","DOI":"10.4088\/JCP.v65n0405","article-title":"A multicenter, randomized, double-blind, placebo-controlled trial of extended-release carbamazepine capsules as monotherapy for bipolar disorder patients with manic or mixed episodes","volume":"65","author":"Weisler","year":"2004","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.jad.2007.02.006_bib28","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1192\/bjp.133.5.429","article-title":"A rating scale for mania: reliability, validity and sensitivity","volume":"133","author":"Young","year":"1978","journal-title":"Br. J. Psychiatry"}],"container-title":["Journal of Affective Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503270700078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016503270700078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T11:38:02Z","timestamp":1707737882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016503270700078X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":29,"alternative-id":["S016503270700078X"],"URL":"https:\/\/doi.org\/10.1016\/j.jad.2007.02.006","relation":{},"ISSN":["0165-0327"],"issn-type":[{"value":"0165-0327","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]}}}